FDA Inspection 1325542 - Dayan K. Gandhi, M.D. - July 02, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dayan K. Gandhi, M.D.

Record Details

This FDA Inspection record concerns Dayan K. Gandhi, M.D., with an inspection on July 2, 2026, issued by the Los Angeles District Office, covering human drugs.

Company: Dayan K. Gandhi, M.D.
Inspection Date: July 2, 2026
Product Type: Human Drugs
Office: Los Angeles District Office

Open in Dashboard

ID · 5a4ac2bd-fb08-46a9-98ae-0524106106eb

Violation Codes2

21 CFR 312.6021 CFR 312.64(b)

Full citation text and observation details available on the Dashboard.